Pharmaceutical Works Ltd. STPF "POLYSAN" (Saint Petersburg)

 production, pharmaceutical, pharmacology

Scientific and technological pharmaceutical firm POLYSAN "organized in December 1992 by a team of medical and biological profile of the various agencies of St. Petersburg.
The main activity is the development, production and introduction of modern medicine.

In the company employs a team of Doctors and Candidates of Science, with extensive experience in research work: the chemists, biotechnologists, biologists, patent, clinicians of various specialties, pharmacists.

The result was the development and production of medical practice and domestic pharmaceutical medical product - inductor of endogenous interferon - cycloferon. Initially, medication Cyclopheron designed with the goal of its use in veterinary medicine for the treatment and prevention of viral diseases in domestic animals, while simultaneously conducted research on experimental and clinical study Cyclopheron for implementation in public health practice in the leading medical research centers in the country: Institute of Virology, AMS, NIIEM them . Gamaleia Medical Sciences, Institute of Medical Sciences of influenza, the Research Institute of Traumatology and Orthopedics. Vreden, Military Medical Academy and a number of other equally well-known scientific centers of the country and the institutions of practical public health at the bases of which are clinical faculty of medical colleges.

The culmination of this phase was to permit the production and medical use of drugs Cyclopheron (external link) solution for intravenous and intramuscular drug vvedeniya.Meditsinsky Cyclopheron (external link) registered in Russia, has been patented in the U.S. and Europe. Now established industrial output cycloferon.

Currently approved for use in medical practice and the tablet form (150 mg) Cyclopheron (external link).

In 1999, completed a clinical study of the effectiveness of the solution Reamberin 1.5% for infusion (external link) for endogenous and exogenous intoxications. The drug is permitted for use in medical practice, established industrial output reamberin.
Specialists LLC STPF "POLYSAN" continue to work intensively on the creation of new original drugs.

www.polysan.ru/